Wedbush initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating and $35 price target Light Up your Portfolio with Spark:Easily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback